MSC News

MSC News National Headlines Sports Top Headlines CBS US News CBS Technology

Printer Friendly

Email to a Friend

SEDHD will cease using Johnson & Johnson vaccine

By Submitted

04/13/2021

(KLZA)-- The Southeast District Health Department is pausing administration of the Johnson & Johnson/Janssen COVID-19 vaccine, following the Centers for Disease Control and Prevention and the Food and Drug Administration recommendations.

On Tuesday, April 13th, CDC and FDA released a joint statement recommending a pause on Johnson & Johnson/Janssen vaccinations nationwide after receiving reports of a rare but severe type of blood clot in individuals who have received the Johnson & Johnson/Jansen vaccine.

Only six instances of this severe clotting event have been identified among approximately 6.8 million who have received the Johnson & Johnson/Janssen vaccine across the United States.

The pause is a transparent and deliberate decision to allow time for a thorough review and investigation.

SEDHD is communicating the pause to healthcare providers and pharmacies across the district. Individuals who have received the Johnson & Johnson/Jansen vaccine and develop a severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider.

Any potential adverse reactions to vaccines should be reported into the CDC's Vaccine Adverse Events Reporting System at https://vaers.hhs.gov.

There are currently no recommendations to pause the use of the other two vaccines, Pfizer and Moderna. These two vaccines should be provided in place of the Johnson & Johnson /Janssen vaccine until further notice.

You will need to be logged in to leave a comment.

Please Login

The posting of advertisements, profanity, or personal attacks is prohibited.

Click here to review our Terms of Use.